These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 23590933)
1. Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat. Thirunavukkarasu M; Selvaraju V; Dunna NR; Foye JL; Joshi M; Otani H; Maulik N Int J Cardiol; 2013 Oct; 168(3):2474-80. PubMed ID: 23590933 [TBL] [Abstract][Full Text] [Related]
2. Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction. Oriowo B; Thirunavukkarasu M; Selvaraju V; Adluri RS; Zhan L; Takeda K; Fong GH; Sanchez JA; Maulik N Curr Pharm Des; 2014; 20(9):1305-10. PubMed ID: 23978105 [TBL] [Abstract][Full Text] [Related]
3. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats. Huang D; Wang FB; Guo M; Li S; Yan ML; Yu T; Wei M; Li JB Int J Mol Med; 2015 Mar; 35(3):829-38. PubMed ID: 25524396 [TBL] [Abstract][Full Text] [Related]
4. Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats. Selvaraju V; Suresh SC; Thirunavukkarasu M; Mannu J; Foye JLC; Mathur PP; Palesty JA; Sanchez JA; McFadden DW; Maulik N J Cardiovasc Transl Res; 2017 Apr; 10(2):209-220. PubMed ID: 28281242 [TBL] [Abstract][Full Text] [Related]
5. Protective Effect of Cardiomyocyte-Specific Prolyl-4-Hydroxylase 2 Inhibition on Ischemic Injury in a Mouse MI Model. Pradeep SR; Lim ST; Thirunavukkarasu M; Joshi M; Cernuda B; Palesty JA; Maulik N J Am Coll Surg; 2022 Aug; 235(2):240-254. PubMed ID: 35758926 [TBL] [Abstract][Full Text] [Related]
6. Sitagliptin improves cardiac function after myocardial infarction through activation of autophagy in streptozotocin-induced diabetic mice. Gu Y; Ma CT; Gu HL; Shi L; Tian XT; Xu WQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8973-8983. PubMed ID: 30575942 [TBL] [Abstract][Full Text] [Related]
7. Simvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice. Huang PH; Chen JY; Chen CY; Chen JW; Lin SJ; Shih CC J Vasc Surg; 2016 Oct; 64(4):1112-1120.e1. PubMed ID: 26830691 [TBL] [Abstract][Full Text] [Related]
8. Prolyl hydroxylase inhibitors protect from the bone loss in ovariectomy rats by increasing bone vascularity. Liu X; Tu Y; Zhang L; Qi J; Ma T; Deng L Cell Biochem Biophys; 2014 May; 69(1):141-9. PubMed ID: 24242187 [TBL] [Abstract][Full Text] [Related]
9. Effect of simvastatin on collagen I deposition in non-infarcted myocardium: role of NF-κB and osteopontin. Zhang J; Xu Y; Pan L; Chen T; Chen Z; Zhao R Can J Physiol Pharmacol; 2010 Nov; 88(11):1026-34. PubMed ID: 21076490 [TBL] [Abstract][Full Text] [Related]
10. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats. Zhang M; Gao X; Bai SJ; Ye XM; Zhang J Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508 [TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats. Wang F; Huang D; Zhu W; Li S; Yan M; Wei M; Li J Int J Mol Med; 2013 Nov; 32(5):1037-46. PubMed ID: 24002353 [TBL] [Abstract][Full Text] [Related]
12. Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair. Ghadge SK; Messner M; Van Pham T; Doppelhammer M; Petry A; Görlach A; Husse B; Franz WM; Zaruba MM J Mol Med (Berl); 2017 Aug; 95(8):825-837. PubMed ID: 28550361 [TBL] [Abstract][Full Text] [Related]
13. Ghrelin ameliorates impaired angiogenesis of ischemic myocardium through GHSR1a-mediated AMPK/eNOS signal pathway in diabetic rats. Wang L; Chen Q; Li G; Ke D Peptides; 2015 Nov; 73():77-87. PubMed ID: 26364514 [TBL] [Abstract][Full Text] [Related]
14. Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects. Bauersachs J; Hiss K; Fraccarollo D; Laufs U; Ruetten H Cardiovasc Res; 2006 Dec; 72(3):438-46. PubMed ID: 17026973 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy. Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486 [TBL] [Abstract][Full Text] [Related]
16. Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart independent of cholesterol-lowering effects. Adameova A; Harcarova A; Matejikova J; Pancza D; Kuzelova M; Carnicka S; Svec P; Bartekova M; Styk J; Ravingerova T Physiol Res; 2009; 58(3):449-454. PubMed ID: 19627175 [TBL] [Abstract][Full Text] [Related]
18. Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease. Uchida L; Tanaka T; Saito H; Sugahara M; Wakashima T; Fukui K; Nangaku M Am J Physiol Renal Physiol; 2020 Feb; 318(2):F388-F401. PubMed ID: 31841388 [TBL] [Abstract][Full Text] [Related]
19. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts. Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523 [TBL] [Abstract][Full Text] [Related]